Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis

Archives of Dermatological Research

Volumn 293, Issue 9, 2001, Pages 460-469

  Wataya Kaneda, M ^a   Kaneda, Yasufumi ^a   Hino, Okio ^b   Adachi, Hiroyuki ^b   Hirayama, Youko ^b   Seyama, Kuniaki ^c   Satou, Teruhiko ^c   Yoshikawa, Kunihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cyclin dependent kinase 1 (P34cdc2 or cdc2); Loss of heterozygosity (LOH); MPM2 reactive phosphoprotein (MPP2); Proliferating cell nuclear antigen (PCNA); Tuberous sclerosis complex (TSC)

Indexed keywords

BROXURIDINE; CYCLIN A; CYCLIN B; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PROTEIN KINASE;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE S PHASE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NICK END LABELING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHOOL CHILD; SKIN FIBROBLAST; TUBEROUS SCLEROSIS;

ADULT; APOPTOSIS; BROMODEOXYURIDINE; CELLS, CULTURED; CHILD; CYCLINS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; PROTEINS; REPRESSOR PROTEINS; S PHASE; SKIN; STAINING AND LABELING; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034752345     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030100259     Document Type: Article

References (44)

1. Complete inactivation of the TSC2 gene leads to formation of hamartomas
2. Cylin/PCNA is the auxiliary protein of DNA polymerase-delta
3. 9q34 loss of heterozygosity in tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for TSC1 gene
4. Molecular genetic advances in tuberous sclerosis
5. Monoclonal antibodies to mitotic cells
6. Effect of 5-fiuoro-2′-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect
7. Identification and characterization of tuberous sclerosis gene on chromosome 16
8. The tuberous sclerosis gene on chromosome 9q34 act as a growth suppressor
9. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
10. A link between cyclin A expression and adhesion-dependent cell cycle progression
11. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation
12. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions
13. Abnormal gene expressions of stroma cells in patients with tuberous sclerosis
14. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
15. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis
16. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis
17. Comprehensive mutation analysis of TSC1 and TSC2, and phenotypic correlation in 150 families with tuberous sclerosis
18. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene
19. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
20. Dynamics of DNA replication factories in living cells
21. Cholesterol starvation decreases p34cdc2 kinase activity and arrests the cell cycle at G2
22. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin
23. Identification of cDNAs induced by the tumor suppressor TSC2 gene using a conditional expression system in TSC2 mutant (Eker) rat renal carcinoma cells
24. Four-dimensional control of the cell cycle
25. Cell cycle: Fools rush in
26. Hamartin, the product of tuberous sclerosis (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles
27. Loss of heterozygosity in tuberous sclerosis hamartomas
28. CDK inhibitors: Positive and negative regulators of G1-phase progression
29. Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr
30. Role of the tuberous sclerosis gene-2 product in cell cycle control
31. A role of the tuberous sclerosis gene-2 product during neural differentiation
32. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
33. PCNA, a multifunctional ring on DNA
34. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
35. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
36. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: No evidence for genotype-pheno-type correlation
37. Characterization of monoclonal2 antibodies to bromodeoxyuridine
38. A monoclonal antibody against the nucleus reveals the presence of a common protein in the nuclear envelope, the perichromosomal region and cytoplasmic vesicles
39. The loss of 40KDa chromosomal protein in tuberous sclerosis lesions
40. Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope
41. The tuberous sclerosis 2 gene product, tuberin, functions as aRab5 GTPase activating protein (GAP) in modulating endocytosis
42. Analysis of all exons of TSC1 and TSC2 genes for germline mutations in Japanese patients with tuberous sclerosis: Report of 10 mutations
43. All aboard the cyclin train: Subcellular trafficking of cyclins and their CDK partners
44. Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain